A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD
Clinical trial NCT05643638 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05643638
- Sponsor
- Cynata Therapeutics Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-04
- Primary completion
- 2026-03-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.